Seeking Alpha

Shares of BioDelivery Sciences (BDSI) shoot up 33% premarket after the firm announces a...

Shares of BioDelivery Sciences (BDSI) shoot up 33% premarket after the firm announces a worldwide license and development agreement with Endo Pharmaceuticals (ENDP) for the rights to commercialize chronic pain treatment BEMA Buprenorphine.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)